Patent ID: 8927710
Filing Date: 2015-01-06
Classification: A61K,A61P,C07D

Abstract:
1. A CAP dependent endonuclease inhibitor compound represented by formula (I), a pharmaceutically acceptable salt, or a solvate thereof: wherein: —Z—N(R —Z—N(Rx —Z—C(═O)—N(R —Z—N(R —Z—C(═O)—N(R —Z—S—R —Z—SO —Z—S(═O)—R —Z—N(R —Z—N(R —Z—C(═O)—N(R —Z—N(R —Z—N(R —Z—N(R —Z—N(R —Z—C(═O)—N(R —Z—N(R —Z—SO —Z—N(R —Z—N(R —Z—N(R —Z—C(═O)—N(R —Z—N(R —Z—SO —Z—N(R wherein: a) either A wherein: —Z—S—R —Z—S(═O)—R —Z—SO —C(═O)—C(═O)—R —C(═O)—N(R —Z—N(R —Z—N(R wherein: 1) when A1 is CR R 2) when A R with a proviso that c) R wherein